Analyst Ratings for Ligand Pharmaceuticals Inc. (LGND)

Updated: 2017-07-28

Ligand Pharmaceuticals Inc. (NASDAQ:LGND) was awarded an average rating of Buy from investment analysts following the stock. LGND had previously received a consensus rating of Buy a month ago.

4 analysts declared LGND a buy, 0 gave an overweight rating, 1 issued a hold rating, 0 gave an underweight rating, and 0 issued a sell rating. Over the past 90 days, the number of analysts that are bullish on the stock has increased by 0. During this time, the number of analysts bearish on the stock has increased by 0.

A number of analysts gave price targets for LGND. The highest price target was 160, which equates to a potential upside of 31.95 percent. The most pessimistic analyst gave a price target of 103, implying potential capital losses of -15.06 percent. Note that investment analysts can be biased in their reporting on companies's ratings and price targets.

In the last 30 days, analysts have changed their quarterly earnings estimates upwards by an average of 5.46 percent. That number becomes -21.71 percent if we expand the time horizon to include the past 3 months instead of just one. Meanwhile, fiscal year estimates have been revised upwards by 0.73 percent, compared to last month. If we look at the last 90 days instead, we find a net average change of -5.94 percent in FY estimates.

Another thing investors often look at is the level of agreement among analysts' revisions. Over the past month, 2 analysts increased their quarterly estimates, while 0 analysts made negative revisions. Over the same time period, 1 analysts revised their FY earnings estimates upwards, compared to 0 analysts that revised their FY estimates downwards.

In the trailing 52-weeks, LGND hit 139.79 at the highest peak, while it's lowest trading point was 87.50. Currently the stock is 38.58 percent higher than its low, and 13.26 percent below the high. LGND has a P/E ratio of 0. Investors typically compare the P/E ratio to a company's peers in the industry. The LGND value stock report compares LGND to some of its peers using value stock charts. The stock has a market capitalization of $2.54 billion. LGND will post this quarters earnings in days, on 0000-00-00.